Cargando…
New drugs in cystic fibrosis: what has changed in the last decade?
Cystic fibrosis (CF), a life-limiting chronic disease caused by mutations in the cystic fibrosis transmembrane regulator (CFTR) gene, affects more than 90,000 people worldwide. Until recently, the only available treatments were directed to symptom control, but they failed to change the course of the...
Autores principales: | Roda, Juliana, Pinto-Silva, Catarina, Silva, Iris A.I., Maia, Carla, Almeida, Susana, Ferreira, Ricardo, Oliveira, Guiomar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128052/ https://www.ncbi.nlm.nih.gov/pubmed/35620188 http://dx.doi.org/10.1177/20406223221098136 |
Ejemplares similares
-
Faecal calprotectin and rectal histological inflammatory markers in cystic fibrosis: a single-centre study
por: Roda, Juliana, et al.
Publicado: (2022) -
Pediatric population with cystic fibrosis in the centre of Portugal: candidates for new therapies
por: Roda, Juliana, et al.
Publicado: (2021) -
Neonatal tetanus in Turkey; what has changed in the last decade?
por: Dikici, Bunyamin, et al.
Publicado: (2008) -
What Has Changed in the Last Decade in the Turkish Archives of Otorhinolaryngology?
por: Bayram, Ali
Publicado: (2021) -
Smoking Habits among Italian Adolescents: What Has Changed in the Last Decade?
por: Charrier, Lorena, et al.
Publicado: (2014)